• It's your time to find the health care job that fits you!
  • It's your choice to choose a health care recruiting firm with your interests in mind!
  • It's your turn to find a career in health care that is right for you!
  • It's your move, make it a good one!
  • It's YOUR health care career!
Gastroenterology News

Inflammatory Effect On Intestinal Lining Explained By Feedback Loop

Sat, 20 Mar 2010 00:00:00 PDT
Signals released by immune cells during a bout of inflammatory bowel disease interfere with intestinal cells' ability to regenerate. Yet people with inflammatory bowel diseases have a significantly higher risk of developing colon cancer: a hyper-activation of growth in those same intestinal cells...

Shift Workers At More Risk For Irritable Bowel Syndrome
Fri, 19 Mar 2010 02:00:00 PDT
Nurses participating in shift work, especially those working rotating shifts, face a significantly increased risk of developing Irritable Bowel Syndrome (IBS) and abdominal pain compared to those working a standard day-time schedule, according to research published in the American Journal of Gastroenterology...

New Omega-3 Preparation Protects Against Bowel Polyps
Fri, 19 Mar 2010 02:00:00 PDT
A new preparation of an omega-3 polyunsaturated fatty acid found naturally in fish, offers hope for thousands of patients at risk of developing an inherited form of bowel cancer, a new study shows...

Studies Show Significant Increases Of C. Difficile Infections (CDI)
Fri, 19 Mar 2010 02:00:00 PDT
Clostridium difficile infections (CDIs) are quickly becoming a significant issue in healthcare based upon recent studies. Preliminary data collected from nursing homes and highlighted in a Supplementary Pennsylvania Patient Safety Advisory shows that almost 40 percent of gastrointestinal infections reported are CDIs...

Alkermes Announces Initiation Of Multidose Phase 1 Clinical Study Of ALKS 37 For The Treatment Of Opioid-Induced Constipation
Fri, 19 Mar 2010 01:00:00 PDT
Alkermes, Inc. (NASDAQ: ALKS) announced the initiation of a multidose phase 1 clinical study of ALKS 37, an orally active, peripherally-restricted opioid antagonist with potential to block the effects of opioid agonists on gastrointestinal motility, commonly referred to as opioid-induced constipation (OIC)...


 



SEARCHING FOR A JOB!
Contact us by filling out the simple form below to get started.